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Abstract
Background: The proper estimate of the risk of recurrences in early-stage oral tongue squamous cell
carcinoma (OTSCC) is mandatory for individual treatment-decision making. However, this remains a
challenge even for experienced multidisciplinary centers.
Objectives: We compared the performance of four machine learning (ML) algorithms for predicting
the risk of locoregional recurrences in patients with OTSCC. These algorithms were Support Vector
Machine (SVM), Naive Bayes (NB), Boosted Decision Tree (BDT), and Decision Forest (DF).
Materials and methods: The study cohort comprised 311 cases from the five University Hospitals in
Finland and A.C. Camargo Cancer Center, São Paulo, Brazil. For comparison of the algorithms, we
used the harmonic mean of precision and recall called F1 score, specificity, and accuracy values.
These algorithms and their corresponding permutation feature importance (PFI) with the input
parameters were externally tested on 59 new cases. Furthermore, we compared the performance of the
algorithm that showed the highest prediction accuracy with the prognostic significance of depth of
invasion (DOI).
Results: The results showed that the average specificity of all the algorithms was 71%  The SVM
showed an accuracy of 68% and F1 score of 0.63, NB an accuracy of 70% and F1 score of 0.64, BDT
an accuracy of 81% and F1 score of 0.78, and DF an accuracy of 78% and F1 score of 0.70.
Additionally, these algorithms outperformed the DOI-based approach, which gave an accuracy of
63%. With PFI-analysis, there was no significant difference in the overall accuracies of three of the
algorithms; PFI-BDT accuracy increased to 83.1%, PFI-DF increased to 80%, PFI-SVM decreased to
64.4%, while PFI-NB accuracy increased significantly to 81.4%. Conclusions: Our findings show
that the best classification accuracy was achieved with the boosted decision tree algorithm.
3Additionally, these algorithms outperformed the DOI-based approach. Furthermore, with few
parameters identified in the PFI analysis, ML technique still showed the ability to predict locoregional
recurrence. The application of boosted decision tree machine learning algorithm can stratify OTSCC
patients and thus aid in their individual treatment planning.
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1.  Introduction
Oral tongue squamous cell carcinoma (OTSCC) refers to squamous cell carcinoma that arises
from the anterior two thirds of the tongue (also known as mobile tongue). It is usually
reported as part of oral squamous cell carcinoma (OSCC), which includes all anatomical
subsites of the oral cavity. A recent international study including 22 registries reported
89,212 incident cases of OTSCC and an increasing annual incidence [1], which has been
confirmed by others [2]. The primary treatment of choice for OTSCC is surgical excision.
However, even early-stage tumors may express a pattern of aggressive behavior [3,4]. Thus,
OTSCC with aggressive behavior and those with advanced stage require multimodality
treatment including neck dissection and adjuvant (chemo)radiotherapy. Therefore, it is
important to precisely estimate the clinical behavior and outcome of OTSCC. Predicting the
risk of recurrences is one of the important assessments for the clinician during treatment
planning. More importantly, early diagnosis and predicting the risk of recurrences form a
milestone in the management of OTSCC as the recent analysis of Finnish cases reported that
about 67% of OTSCC cases were diagnosed at an early stage (I-II) [5].  With accurate and
timely recurrence prediction, high-risk cases of OTSCC can be identified and multimodality
treatment applied accordingly. In a large cohort of early OTSCC, about one fourth of cases
(27.8%) developed a recurrence, and all of them might have benefitted from early prediction
and corresponding treatment planning [6].
4Many recent studies have examined the use of machine learning (ML) techniques for
prognostication of different cancers [7,8]. Interestingly, predicting patient outcome by ML
techniques has shown better accuracy than Cox regression [9]. This is why the use of ML has
been in active research focus during recent years. For instance, ML techniques have been
used to predict the outcome of various cancer types [10 12] and a web-based tool based on
artificial neural network to predict outcome in cancer has been reported [13].
In this study, we examined four different ML algorithms, namely, support vector
machine (SVM), naive Bayes (NB), boosted decision tree (BDT), and decision forest (DF) in
terms of their performances to predict locoregional recurrence in OTSCC patients. Also, the
predictive performance of a permutation feature importance (PFI) of these algorithms was
evaluated. Many researchers have used this approach for comparing ML techniques for
survival prediction in different malignancies like breast and lung cancers [14 17]. Tapak et
al. examined six ML algorithms and two traditional methods for the prediction of breast
cancer survival and metastasis [15]. In our study, we aimed to identify the best algorithm that
would effectively classify patients as either low-risk or high-risk OTSCC recurrence. The
algorithm with the overall best classification performance was further compared to a recently
reported risk model based on the depth of invasion (DOI) [18]. This comparison was a result
of the fact that DOI of 4mm or deeper has been considered to be a factor that accurately
predicts locoregional recurrence [6]. Moreover, the recent American Joint Committee on
Cancer (AJCC) 8th edition incorporated depth of invasion (DOI) into T-stage [19]. Similarly,
the study by Almangush et al. suggested that DOI is one of the strongest pathological
predictors for locoregional recurrence [6]. This suggestion is in agreement with reports by
others [20,21].
We hypothesize that the application of the above-mentioned supervised learning
classifiers may be used in the prediction of OTSCC locoregional recurrences and will thereby
add value for the management of OTSCC.
52.  Material and Methods
Patients: We used data from a study cohort comprising patients treated at the five Finnish
University Hospitals of Helsinki, Oulu, Turku, Tampere, and Kuopio and at the A.C.
Camargo Cancer Center, Sao Paulo, Brazil. This is a multicenter study from six institutions
and data were provided for many cases as locoregional recurrences without specification. The
clinicopathologic characteristics of this cohort have been previously reported and
summarized [22]. The primary treatment for all cases was surgical excision. In addition, some
cases received neck dissection and/or adjuvant radiotherapy.  The parameters included were
age, gender, T-stage, WHO grade, tumor budding, depth of invasion, worst pattern of
invasion (WPOI), lymphocytic host response (LHR), and perineural invasion (PNI) as shown
in Table 1. Several studies have confirmed the prognostic importance of these variables
[6,13,22 25]. Neck dissection and adjuvant radiotherapy were also included in the machine
learning algorithms due to the impact of variation in the treatment modality that might
influence the risk of recurrence. The use of patient samples and data inquiry were approved
by the Hospital Research Ethics Committees of all individual hospitals, by the Finnish
National Supervisory Authority for Welfare and Health (VALVIRA) and by the Brazilian
Human Research Ethics Committee.
2.1. The classification algorithms examined
The algorithms considered in this study are basic and have been commonly used in other
cancer studies [14 18].
2.1.1. Support vector machine (SVM) is an elegant and powerful ML technique extensively
used for both classification and regression problems [26]. This is due to its ability to classify
6non-linearly separable patterns by projecting the original features into a higher dimensional
space (hyperplane) [27].
2.1.2. Naive Bayes (NB) is known as Bayes point machine in the Azure ML studio and it is
based on the generally-known Bayes theorem [26,27]. The algorithm operates by learning
and estimating the prior probability of belonging to each class using the training data.
[27,28].
2.1.3. Boosted Decision Tree (BDT) with gradient boosting machine was the subtype of BDT
used in this study. It is an ensemble learning method where the second tree corrects the errors
of the first tree, the third tree corrects the errors in the second trees, the fourth tree corrects
the errors in the third trees, etc. Predictions are based on the entire ensemble of trees [27,28].
2.1.4. Decision Forest (DF) relies on the combination of multiple related models to get better
results and a more generalized model. Therefore, it works by using a bootstrapped sample of
data to build each tree where only a proportion of the variable set is considered for each tree.
Each tree in the decision forest outputs a frequency histogram of labels that is non-
normalized. These frequency histograms were aggregated in the process that sums these
histograms and then normalizes the results to get the probabilities for each label [27].
2.1.5. Permutation Feature Importance (PFI) is a model-agnostic ranker feature ranker that
computes the scores for each of the variables contained in a dataset. It basically examines the
contribution of each feature to the overall predictive performance of the algorithm [27].
2.2. Evaluation of the performance of the algorithms
7The performance metrics were aimed to evaluate how the algorithms performed [29 31].
Most of these metrics have been previously used in other studies [15,32]. However, in
addition to accuracy, only two (F1 score and specificity) of these statistical measures that are
medically more relevant in the clinic, were discussed in the current study.
3. The training-validation phase for the algorithms in Microsoft Azure for prediction of
recurrence
Microsoft Azure Machine Learning Studio (Azure ML 2019) was used in this study [27]. The
data was preprocessed to handle missing values. The input parameters were age, gender,
stage, grade, tumor budding, depth of invasion (DOI), worst pattern of invasion (WPOI),
lymphocytic host response (LHR), perineural invasion (PNI) and treatment given, while the
target output was locoregional recurrence. Disease-free survival (DFS) time of the cases
ranged from 1 to 267 months. Specifically, the DFS in cases with recurrence varied between
1 and 120 months. Firstly, a potential class imbalance with respect to the number of patients
who experienced a tumor recurrence in the target class (locoregional recurrence) was handled
by up-sampling in order to balance the classes used in the training. Synthetic minority
oversampling technique (SMOTE) [33] offers a better way to handle imbalance than simply
duplicating existing cases. The dataset and the corresponding samples are therefore more
general [33]. The dataset was divided into two sets of training and validation. Due to the
relatively limited amount of data, a 5-fold cross validation was used with 50% training and
50% validation {50:50} percentage splitting sets [15]. Each of the algorithms of interest was
then configured as shown in Figure 1 [27,28]. After training, the algorithms were evaluated
for the various quality metrics (Table 3).
Furthermore, these algorithms were further tested with new cases (Section 3.1). The
result obtained from this approach was considered as the gold standard in this study as it
gives an account of how the algorithm is expected to predict in reality. Also, it addresses any
8concerns about the generalizability of the trained models. In addition, the contribution of each
of the input variables on the predictive ability of each model was examined using permutation
feature importance (PFI) analysis. Their contributions were given in the form of PFI-
performance scores. To avoid bias in the algorithm, disease-free survival and treatment were
removed from the PFI analysis that was aimed to examine the predictive ability of each
variables. The input features with positive scores were selected. Also, only one of the inputs
was selected when two or more inputs give the same negative score. The variables with least
scores were not selected. These selected variables were used to train the algorithms. The
given accuracies in the PFI analysis were compared with the accuracies obtained without PFI.
Similarly, the PFI-based algorithms were tested with new cases.
3.1 Testing performance of the model with new cases: In this phase, the trained algorithms
were tested with 59 new cohort cases that were not included in the training or in the
validation sets (Figure 1). These new independent data were obtained from a cancer center in
Brazil. The results are presented in Table 4. The PFI-based models were also tested with
these new cases as presented in Table 5.
3.2 Comparison with the depth of invasion (DOI): The algorithm that showed the highest
overall accuracy when tested with these new external cases (section 3.1) was also compared
with the depth of invasion (DOI) based model as shown in Figure 3.
4. Results
4.1 Data Description
The study cohort included 311 patients with cT1-T2cN0M0 OTSCC; 165 men and 146
women, resulting in a male-to-female range of 1.1:1. Out of these 311 cases, 57 cases had
missing details about any postoperative treatment information. Therefore, these cases were
excluded and the machine learning training was performed with 254 cases. These cases
9included 141 men and 113 women with the mean age at diagnosis was 61.51 (SD 14.81:
range 10-95) and the median age was 62.0 years. The distribution according to tumor
diameter showed that 100 patients had stage T1 and 154 stage T2. The histopathologic
parameters are briefly summarized in Table 2. In terms of the treatment, 157 patients had
surgery alone while 97 had adjuvant (chemo)radiotherapy (92 radiotherapy and 5
chemoradiotherapy) . Similarly, 185 had neck dissection while 69 had no neck dissection
performed. Thus, from the 185 patients who had neck dissection, 43% were exposed to
adjuvant radiotherapy while 57% had only surgery as single-modality treatment. Similarly,
out of the 69 cases who had no dissection performed, 25% were exposed to adjuvant
radiotherapy while 75% had only surgery.
The number of patients with disease recurrences was 68 (26.8%). While the disease-
free survival (DFS) time ranged from 1 to 267 months, the DFS time for cases with a
locoregional recurrence was between 1 to 120 months. Overall, 89.6% of the recurrences
occurred in the first 2 years, while 10.45% recurrence was recorded after 2 years. The mean
follow-up time was 75 months (SD  64.6; range 1 - 258 months) and the median was 60
months. Similarly, for the 59 new OSCC cases used for external testing, DFS time varied
between 1 to 146 months. Also, 74% had a recurrence in the first year, 16% after the first and
before end of second year, and 10% of the patients recurred after the second year. The mean
age in this external validation cohort was 56.2 years (range, 31-84 years). All these new cases
had neck dissection, where 34 cases had surgery alone while 25 had adjuvant
(chemo)radiotherapy (22 radiotherapy and 3 chemoradiotherapy). The DOI model
performance in terms of accuracy in the training set was 47.2% and the overall accuracy in
the new cohorts used for external validation was 63%.
Performance metrics for the algorithms
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The distribution of true and false positives, true and false negatives, and other performance
metrics for the algorithms in the training phase are given in Figure 2a and Table 3,
respectively. During the training phase, decision forest showed the highest accuracy while
naive Bayes and decision forest showed the best area under receiving operating characteristic
(AUC of ROC). When these algorithms were tested on the 59 new external cases from the
cancer center in Brazil, the average specificity of all the algorithms was 71%. The tested
algorithms i.e. support vector machine, naive Bayes, decision forest, and boosted decision
tree gave an overall accuracy of 68%, 70%, 78% and 81%, respectively. The details of the
performance of parameters with this new cohorts are given in Table 4. Considering the
harmonic mean of precision and recall, that is, F1 score, the support vector machine, naive
Bayes, decision forest, and boosted decision tree gave 0.63, 0.64, 0.70 and 0.78, respectively.
Therefore, the best overall classification performance to predict recurrence was achieved with
the boosted decision tree algorithm. Comparison of the boosted decision tree algorithm and
the DOI model is shown in Figure 3; the DOI model showed an accuracy of 63% where
54.1% of the patients would be observed, thereby not subjected to adjuvant therapy or
elective neck dissection (END). The boosted decision tree on the other hand showed 81%
overall accuracy where 21.1% of the patients would have been observed and not subjected to
END. Similarly, about half (49.5%) of the patients were correctly identified as having
OTSCC recurrence using the DOI model. Boosted decision tree machine learning technique
correctly identified 78.9% as having OTSCC recurrence as shown in Figure 3. Thus, each of
these algorithms performed significantly better than the DOI-based model.
The results of the permutation feature importance (PFI) analyses are given in Table 5.
The PFI scores were calculated for each feature independently. A zero score is returned when
there is no difference in the performance metrics before and after PFI of that feature.
Similarly, a negative score is returned when a random PFI of that feature produced a higher
accuracy and lower error (better performance metrics) compared to the performance before
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PFI was applied. Moreover, a higher importance score (positive) gives an indication of the
contribution of that feature to the predictive ability of the model. The PFI of boosted decision
tree (PFI-BDT) showed the highest accuracy (83.1%). Also, it was observed that the accuracy
of BDT increased from 81.0% to 83.1% and DF increased from 78% to 80%, while SVM
showed a reduction in accuracy from 68% to 64.4% in the PFI analysis. Interestingly, the
accuracy of NB increased significantly from 70.0% to 81.4% in the permutation feature
importance fitting. The ranking of the scores of the features is as shown in Table 5.
5. Discussion
The present study compared the performance of ML algorithms to stratify patients with
OTSCC into low or high-recurrence risk group. In this regard, four ML algorithms, namely,
boosted decision tree, naive Bayes, support vector machine, and decision forest were
examined. We found that the performance of these techniques was higher than that of depth
of invasion (DOI) based approach. Our multicenter cohort of cases is one of the largest
published series. Majority of the previous publications including hundreds of cases have
mixed early-stage cases with those with advanced stage, and/or have mixed different subsites
of the oral cavity (e.g. oral tongue with floor of mouth and retromolar region). Therefore,
heterogeneity of such series makes it difficult to identify robust prognostic markers. The
advantage of our homogenous cohort (only early stage and only oral tongue) allows for
reaching definitive conclusions that can be considered to be applied in daily practice.
Although significant progress has been made in early diagnostics, treatment strategies
and prevention of OTSCC in recent years, the prognosis of OTSCC is poor due to aggressive
local invasion and metastasis, leading to recurrence. The mortality rates in cases with
recurrence has been reported to be very high [34]. When recurrence is diagnosed earlier, the
mortality rates have been reported to decrease [35,36]. The reported rates of recurrence in
oral squamous cell carcinoma range from 6.9 % to 37.4% of patients [37,38]. This is in
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accordance with the 26.8% locoregional recurrence rate within the dataset used in this study.
Improved prediction of locoregional recurrences in early-stage OTSCC can lead to an
adjusted, patient-oriented follow-up program. For example, based on prediction of the patient
as a high-risk case, a customized surveillance could be organized instead of the general
follow-up program.
Abundant studies exist that have considered DOI as a strong histologic feature that
correlates with locoregional recurrence. The machine learning algorithms examined in this
study, however, outperformed the power of prediction of locoregional recurrence based on
DOI. However, it will offer a better approach with significant accuracy in stratifying the
patients as carrying a high- or low-risk for recurrence. Therefore, it seems obvious, that the
described challenge in the treatment-decision making would be successfully addressed by the
machine learning model due to increased specificity, F1 score and overall accuracies of the
ML algorithms. Thus, this study has potentially high impact to clinicians in the management
of early OTSCC.
With regards to the performance metrics examined, F1 score used as the benchmark
to choose the best algorithm as it finds the optimal blend between two other performance
metrics (precision and recall). As shown in Table 4, the F1 score for the boosted decision tree
algorithm showed to be very good at stratifying the patients as having either low-risk or high-
risk of recurrence of OTSCC. This justifies why boosted decision tree was compared to the
DOI as shown in Figure 3 [18]. It is important to note that the support vector machine showed
promising evaluation performance metrics in the training phase. This is due to the fact that it
is an empirical risk minimizer algorithm. Hence, it is not usually prone to overfitting related
issue as it avoids the danger of getting trapped into local minima [39]. However, the
ensemble algorithms performed better than the support vector machine because they were
able to create a fleet of algorithms with relatively similar bias and subsequently combining
their outputs to reduce variance.
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Furthermore, a major challenge in the treatment of patients with early OTSCC is in
finding the right parameters that predict prognosis and help to properly identify patients at
high risk of locoregional recurrences. This would carry the potential to minimize the
incidence treatment failure of patients with OTSCC [35]. With the PFI-analyses, the exact
contribution of each parameter to the predictive ability of the machine learning algorithms
was known. Interestingly, there was no significant difference in the overall accuracies
achieved  in the ensemble methods (decision forest and boosted decision tree) with reduced
parameters identified in the PFI analyses compared to the algorithms without PFI. Therefore,
the cost and resources associated with getting numerous parameters can be properly
managed. Also, the time taken to properly prepare an individualized treatment plan for the
patients can be improved. This is because a few but important features that are needed for the
ML algorithms were identified in the PFI analysis while producing the same range of
prediction accuracies. Thus, predicting recurrence with such accuracy as shown in this study
would be crucial to the clinicians in terms of management decisions.
Numerous studies have compared the performance of various machine learning
classifiers to predict an outcome of interest in cancer. Tapak et al. compared various machine
learning classifiers in series of 550 breast cancer patients, and found that the support vector
machine predicted survival better than other classifiers [15]. Similarly, the study by Tseng et
al. compared decision tree ML technique with a traditional statistical model such as logistic
regression in series of 673 oral cancer patients and the decision tree was found to perform
better [40]. De Melo et al. used decision tree to evaluate the quality of life among patients
with head and neck cancer [41]. Similarly, Sumbaly et al. used the decision tree in the
diagnosis of breast cancer [42]. The decision forest also produced the highest prognostic
performance when compared with other machine algorithms by Zhang et al. for the
radiomics-based prediction of failure in advanced nasopharyngeal carcinoma [43].
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In conclusion, this study investigated four different ML algorithms and found that the
boosted decision tree algorithm showed the best overall performance accuracy. Due to the
sensitive nature of the application of machine learning in medicine, it is important for these
algorithms to produce very high accuracies. In this study, the ensemble algorithms such as the
boosted decision tree and the decision forest algorithms performed better than non-ensemble
algorithms such as support vector machine, naive Bayes and a method based on depth of
invasion. Therefore, the ensemble machine algorithms should be considered in medical
applications. Presently, it is challenging for clinicians to assess the outcomes of clinical early-
stage oral cancer. For the clinicians, knowledge of potential locoregional prediction to stratify
the patients into low-risk or high-risk groups using machine learning applications can help to
guide clinical practice. Patients can be counseled accordingly with realistic expectations and
clinicians can be guided in making informed decisions. Furthermore, this contributes to the
individual data regarding patient and tumor-related factors and thereby helps the clinician in
planning the optimal patient-specific treatment and follow-up (post-operative adjuvant
treatment). For instance, high-risk patients might benefit from adjuvant oncological therapy
after surgery. Future research should consider including other prognostic parameters as inputs
for the selected algorithms. In terms of the limitation of this study, we are limited by the
number of available cases as this was a retrospective study of five teaching hospitals in
Finland and one in Brazil. Also, the external data used to test the performance of the
algorithms were relatively limited. Therefore, with larger external data, the performance of
the algorithms could be improved.
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Summary points
What was already known on the topic:
There are few published studies on the comparison of  machine learning techniques to
predict locoregional recurrence of oral tongue squamous cell carcinoma (OTSCC).
Accuracy value is the most considered performance metrics to choosing the machine
learning technique for prediction.
What knowledge this study adds:
To the best of our knowledge, this is the first study that analyzed more than three
machine learning techniques to predict risk of locoregional recurrence in oral tongue
squamous cell carcinoma (OTSCC) as low-risk or high-risk.
It is important to consider other performance metrics such as specificity and F1 score
(weighted average of precision and recall) in medical applications.
The permutation importance feature (PFI) algorithm to extract important features does
not correspond to better overall prediction and does not necessarily perform better
than the ensemble algorithms.
The application of these supervised learning techniques to stratify the patients as
having low-risk or high-risk for the recurrence of OTSCC may be useful for effective
cancer management.
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Figure Legend
Figure 1. The training process in azure machine learning studio.
Figure 2. The classification results of the four basic parameters for each algorithm in the
training and also for PFI analysis.
(TP: True Positive, TN: True Negative, FP: False Positive, FN: False Negative, BDT: Boosted Decision Tree, SVM: Support
Vector Machine, NB: Naive Bayes, and DF: Decision Forest).
Figure 3. The comparison of the boosted decision tree algorithm to the depth of Invasion
model [18]
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Table 1. The parameters contained in the dataset and their respective descriptors.
Number      Parameters                                      Description                                                        Type
1
2
Age
Gender
Age at the time of diagnosis
The sexual orientation of the patient
Discrete
Categorical
1 = Male; 2 = Female
3 T-stage T stage describing tumor size Categorical
1 = T1; 2 = T2.
4 WHO Grade Histopathologic grading according to
World Health Organization (WHO) criteria
Categorical
1 = Grade I; 2 = Grade II; 3 =
Grade III
5 Tumor budding Tumor budding is defined as the presence
of single cells or small clusters
of cancer cells detached from the main
tumor mass
Categorical
0 = No budding; 1 <  5 buds;
2 for 5 buds.
6 Tumor depth This is the measure of tumor depth of
invasion. It was measured in millimetres
(mm)
Categorical
1 for < 4mm,
2 for 4mm
7 WPOI Worst pattern of invasion Categorical
Value of 0 for WPOI type 1
to 3; Value of 1 for WPOI
type 4; Value of 3 for WPOI
type 5.
8 LHR Lymphocytic host response Categorical
Value of 0 for LHR type 1;
Value of 1 for LHR type 2;
Value of 3 for LHR type 3.
9 PNI Perineural invasion Categorical
0 = Absent; 1 = Present
10 Treatment This indicates the type of treatment offered
for the patient. It could either be surgery
alone or adjuvant (chemo)radiotherapy in
addition to the surgery
Categorical
0 = Surgery alone
1 = Surgery + Adjuvant
(chemo)radiotherapy
11 Neck treatment This variable indicates whether neck
dissection was performed or not
Categorical
0 = No neck dissection
1 = Neck dissection
performed.
12 Recurrence* The occurrence of disease after treatment Categorical
0 = Low-Risk; 1 = High-Risk
* Recurrence was considered as the output/target label. The disease-survival (DFS) ranges from 1 to 267 months
while DFS for locoregional recurrence patient ranges from 1 to 120 months.
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Table 2: Summary of histopathologic parameters included for the machine learning
training.
Variable Category (Definition) Number
WHO grade
Grade I (Well-differentiated tumor) 78
Grade II (Moderately-differentiated tumor) 103
Grade III (Poorly-differentiated tumor) 73
Tumor budding
None (There is no tumor budding) 93
Low (Tumor has less than five buds) 85
High (Tumor has five buds or more at the invasive
front)
76
Depth of invasion
Superficial (Tumor < 4 mm in depth) 96
Deep (Tumor  4 mm in depth) 158
Worst pattern of invasion
(WPOI)
32
Type 3 (Weak) 130
Perineural invasion (PNI)
Absent (PNI was not observed) 223
Present (PNI was observed) 31
Table 3. The overall performance metrics of the classifiers in the training phase
BDT = Boosted Decision Tree, SVM = Support Vector Machine,  BPM = Bayes Point
Machine, DF = Decision Forest, Precision (PPV = Predictive positive value), NPV =
26
Negative predictive value, LR+ = Positive likelihood ratio and LR- = Negative likelihood
ratio, Sensitivity (recall), Area under receiving operating characteristics curve (AUC), and
CDE = Custom Designed Ensemble.
Table 4. The performance of the algorithms with external cases.
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Table 5. Permutation Feature Importance (PFI ) of the algorithms.
* Negative score.  DF : Decision Forest, BDT: Boosted Decision Forest, SVM: Support
Vector Machine, NB: Naive Bayes. WPOI: Worst Pattern of Invasion, PNI: Perineural
Invasion, LHR: Lymphocytic host response.
